Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

被引:71
作者
Okada, N
Tsukada, Y
Nakagawa, S
Mizuguchi, H
Mori, K
Saito, T
Fujita, T
Yamamoto, A
Hayakawa, T
Mayumi, T
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Suita, Osaka 5650871, Japan
[2] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan
[3] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan
基金
日本学术振兴会;
关键词
adenovirus vector; dendritic cell; Coxsackie-adenovirus receptor; alpha(v)-integrin; fiber-mutant; Arg-Gly-Asp sequence; gene-immunotherapy;
D O I
10.1006/bbrc.2001.4527
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have demonstrated the usefulness of dendritic cells (DCs) genetically modified by adenovirus vectors (Ad) to immunotherapy, while sufficient gene transduction into DCs is required for high doses of Ad. The RT-PCR analysis revealed that the relative resistance of DCs to Ad-mediated gene transfer is due to the absence of Coxsackie-adenovirus receptor expression, and that DCs expressed adequate alpha (nu)-integrins, Therefore, we investigated whether fiber-mutant Ad containing the Arg-Gly-Asp (RGD) sequence in the fiber knob can efficiently transduce and express high levels of the LacZ gene into DCs. The gene delivery by fiber-mutant Ad was more efficient than that by conventional Ad in both murine DC lines and normal human DCs (NHDC). Furthermore, NHDC transduced with fiber-mutant Ad and conventional Ad at 8000-vector particles/cell resulted in a 70-fold difference in beta -galactosidase activity. We propose that alpha (nu)-integrin-targeted Ad is a very powerful tool with which to implement DC-based vaccination strategies. (C) 2001 Academic Press.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 30 条
[1]  
Arthur JF, 1997, CANCER GENE THER, V4, P17
[3]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[4]   High efficiency adenovirus-mediated gene transfer to human dendritic cells [J].
Dietz, AB ;
Vuk-Pavlovic, S .
BLOOD, 1998, 91 (02) :392-398
[5]   MURINE DENDRITIC CELLS PULSED IN-VITRO WITH TUMOR-ANTIGEN INDUCE TUMOR RESISTANCE IN-VIVO [J].
FLAMAND, V ;
SORNASSE, T ;
THIELEMANS, K ;
DEMANET, C ;
BAKKUS, H ;
BAZIN, H ;
TIELEMANS, F ;
LEO, O ;
URBAIN, J ;
MOSER, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (03) :605-610
[6]   THE BIOCHEMISTRY AND CELL BIOLOGY OF ANTIGEN PROCESSING AND PRESENTATION [J].
GERMAIN, RN ;
MARGULIES, DH .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :403-450
[7]   ESTABLISHMENT OF A CELL-LINE WITH FEATURES OF EARLY DENDRITIC CELL PRECURSORS FROM FETAL MOUSE SKIN [J].
GIROLOMONI, G ;
LUTZ, MB ;
PASTORE, S ;
ABMANN, CU ;
CAVANI, A ;
RICCIARDICASTAGNOLI, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) :2163-2169
[8]   Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells [J].
Gong, J ;
Chen, L ;
Chen, D ;
Kashiwaba, M ;
Manome, Y ;
Tanaka, T ;
Kufe, D .
GENE THERAPY, 1997, 4 (10) :1023-1028
[9]   Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity [J].
Jonuleit, H ;
Tüting, T ;
Steitz, J ;
Brück, J ;
Giesecke, A ;
Steinbrink, K ;
Knop, J ;
Enk, AH .
GENE THERAPY, 2000, 7 (03) :249-254
[10]   GENE-THERAPY FOR METABOLIC DISORDERS [J].
KAY, MA ;
WOO, SLC .
TRENDS IN GENETICS, 1994, 10 (07) :253-257